

Penn Scientists Just Supercharged mRNA Vaccines—And It Could Be a Game-Changer for Cancer, COVID, and Beyond
What if one tweak to a vaccine could make it last longer, hit harder, and work better across more people? That’s exactly what a team of researchers at Penn Vet, Penn Medicine, and CHOP may have unlocked with their latest study—by boosting mRNA vaccines with a powerful immune molecule called IL-12.